Ramos S, Goya L, Alvarez C, Martín M A, Pascual-Leone A M
Instituto de Bioquímica (Centro Mixto CSIC-UCM), Facultad de Farmacia, Ciudad Universitaria, 28040 Madrid, Spain.
J Endocrinol. 2001 Apr;169(1):111-22. doi: 10.1677/joe.0.1690111.
The effects of different doses of thyroxine (T(4)) delivered by injection or s.c. pellet implantation on alterations of the IGF/IGF binding protein (IGFBP) system were studied in neonatal and adult thyroidectomized (Tx) rats. Body weight, blood glucose, plasma insulin, TSH and GH and pituitary GH content, as well as serum IGF-I, IGF-II, IGFBP-1, -2 and -3 and their liver mRNA expression were assayed. Pellet implantation with the smaller dose of T(4) (1.5 microg/100 g body weight (b.w.) per day) in Tx neonatal rats decreased serum IGF-I, -II and the 30 kDa complex of IGFBPs (IGFBP-1 and -2), and increased serum IGFBP-3. Only the larger dose of T(4) (3 microg/100 g b.w. per day) recovered liver mRNA expression of IGF-I and ensured euthyroid status as shown by the normalized levels of plasma TSH. The rapid increase of body weight and serum GH after T(4) administration indicated a high sensitivity to T(4) during the neonatal period. Serum and liver mRNA expression of IGFs and plasma insulin and GH recovered in adult Tx rats after pellet implantation of 1.75 microg/100 g b.w. per day throughout 10 days. The continuous replacement of T(4) by pellet seems to be the most suitable method for thyroid rehabilitation. A very good correlation was found between insulin and IGF-II in Tx neonates treated with T(4) but not between insulin and IGF-I in Tx adults. IGFBP-2 seems to be up-regulated by T(4) deprivation in neonatal and adult rats. Finally, a good correlation as well as a partial correlation were found between IGFs and thyroid hormones in both neonatal and adult Tx populations, suggesting a direct effect in vivo of T(4) on the hepatic secretion of IGFs, as previously suggested in vitro.
在新生和成年甲状腺切除(Tx)大鼠中,研究了通过注射或皮下植入不同剂量甲状腺素(T4)对胰岛素样生长因子/胰岛素样生长因子结合蛋白(IGFBP)系统改变的影响。测定了体重、血糖、血浆胰岛素、促甲状腺激素(TSH)和生长激素(GH)以及垂体GH含量,以及血清胰岛素样生长因子-I(IGF-I)、胰岛素样生长因子-II(IGF-II)、胰岛素样生长因子结合蛋白-1(IGFBP-1)、-2和-3及其肝脏mRNA表达。在Tx新生大鼠中,植入较小剂量的T4(每天1.5μg/100g体重(b.w.))可降低血清IGF-I、IGF-II以及IGFBPs的30kDa复合物(IGFBP-1和-2),并增加血清IGFBP-3。只有较大剂量的T4(每天3μg/100g b.w.)可恢复IGF-I的肝脏mRNA表达,并通过血浆TSH的正常水平确保甲状腺功能正常状态。T4给药后体重和血清GH的快速增加表明新生期对T4高度敏感。在成年Tx大鼠中,每天植入1.75μg/100g b.w.的T4颗粒10天后,血清和肝脏中IGFs的mRNA表达以及血浆胰岛素和GH恢复正常。通过颗粒持续替代T4似乎是甲状腺功能恢复的最合适方法。在用T4治疗的Tx新生大鼠中,胰岛素与IGF-II之间存在非常好的相关性,但在Tx成年大鼠中胰岛素与IGF-I之间不存在相关性。在新生和成年大鼠中,T4缺乏似乎上调了IGFBP-2。最后,在新生和成年Tx群体中,IGFs与甲状腺激素之间发现了良好的相关性以及偏相关性,这表明T4在体内对肝脏IGFs分泌有直接作用,正如先前在体外所表明的那样。